Halcyon Life Sciences Private Limited
About Halcyon Life Sciences Private Limited
Data last updated:
Halcyon Life Sciences Private Limited is a private limited company based in Chandigarh, India, a subsidiary of Rn Chemicals & Pharmaceutical Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 February 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U85190CH2008PTC031103. Its GSTIN is 04AADCK4208J1ZS (Chandigarh). The company holds 9 GST registrations, of which 3 are active.
The company has an authorised share capital of ₹47 Cr and a paid-up capital of ₹46.48 Cr. It was formerly known as Kiran Flour Mill Industries Private Limited. It is led by directors Anil Kumar Gupta and Neeraj Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No 337, Workyard Industrial And Business Park Phase 2, Chandigarh, India – 160002.
As per the financials filed for FY 2025, the company reported a revenue of ₹26,000, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹28,000 (net margin -107.7%) and EBITDA of -₹28,000 (EBITDA margin -107.7%). Revenue has declined at a compounded annual rate (CAGR) of 28% over three years and 60% over five years.
As per MCA filings, the company has satisfied charges of ₹1,341.31 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it; 1 case is pending. The company has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Halcyon Life Sciences has one previous CIN (Corporate Identification Number): U15311CH2008PTC031103. The current CIN is U85190CH2008PTC031103, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85190CH2008PTC031103 | Current |
| U15311CH2008PTC031103 | Previous |
Contact details
Halcyon Life Sciences Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 337, Workyard Industrial And Business Park Phase 2, Chandigarh, India – 160002
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Halcyon Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Halcyon Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Halcyon Life Sciences Private Limited
FY 2024 filings availableHalcyon Life Sciences Private Limited reported revenue of ₹26,000 (up 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 60%. EBITDA fell 103% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹28,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹28,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -107.7% | ||||
| Net Profit Margin | -107.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Halcyon Life Sciences Private Limited, buy the company report.
Board of directors of Halcyon Life Sciences Private Limited
Halcyon Life Sciences has 2 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Gupta Also directs: Ang Capital Investments Private Limited | Director | 30 Mar 2023 | 3 Years 6 Months | Current |
| Neeraj Gupta Also directs: Lente Waters Private Limited, Ang Healthcare India Private Limited, Recorders & Medicare Systems Private Limited and 1 more | Director | 30 Mar 2023 | 3 Years 6 Months | Current |
Auditor
Halcyon Life Sciences Private Limited is audited by Harjeet Parvesh & co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Harjeet Parvesh & co. | FY 2023 | 017437N |
Shareholding
The shareholding of Halcyon Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Halcyon Life Sciences Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Apr 2014 | 10489632 | State Bank of India | ₹18.46 Cr | Satisfied | |
| 27 Mar 2014 | 10510698 | State Bank of Patiala | ₹20.52 Cr | Satisfied | |
| 31 Dec 2013 | 10515116 | State Bank of India | ₹18.46 Cr | Satisfied | |
| 28 Mar 2013 | 10419786 | Punjab National Bank | ₹1,002.87 Cr | Satisfied | |
| 21 Jan 2012 | 10341415 | State Bank of India | ₹105 Cr | Satisfied |
To see the full charge records of Halcyon Life Sciences Private Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Halcyon Life Sciences Private Limited has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021.
Deals on record (5 of 9)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Funding round | ₹25 Cr | Investors: Ind Swift Laboratories Limited |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Ind Swift Laboratories Limited , Ind Swift Laboratories Limited & Rishav Mehta, Ind Swift Laboratories Limited & Pardeep Verma Seller: Essix Biosciences Limited , 2 individuals |
| Mar 2018 | Acquisition | Undisclosed | Buyer: Essix Biosciences Limited Seller: A.K.J. Portfolios Private Limited , SRM Portfolios Private Limited , V K M Portfolios Private Limited |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: Zeus Trading Enterprise Pte. Ltd Seller: N R M Portfolios Private Limited |
| Jan 2013 | Funding round | ₹8 Cr | Investors: A.K.J. Portfolios Private Limited , N R M Portfolios Private Limited , V K M Portfolios Private Limited |
To see the full deal history of Halcyon Life Sciences Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Halcyon Life Sciences Private Limited has 8 court cases on record: 7 filed by Halcyon Life Sciences, 1 filed against it. 1 case is pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 0 | 1 |
| District courts | 3 | 1 | 0 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Gurugram, Haryana | Cheque dishonour complaint | Filed against the company by Ms Bibby Financial Services India Pvt. Ltd. | Disposed |
| District court, SAS Nagar, Punjab | Civil suit | Filed by the company against Essix Biosciences Ltd | Disposed |
| High Court, HARYANA | Criminal miscellaneous application | Filed by the company against M/S Bibby Financial Services India Pvt. Ltd. | Disposed |
| High Court, JAMMUKASHMIR | Writ petition | Filed by the company against Union of India Th Secretary Deptt of Revenue Ministry of Finance New Delhi and Others | Pending |
| High Court, CHANDIGARH (UT) | Writ petition | Filed by the company against Income Tax Officer and Ors and 4 others | Disposed |
To see the full case history of Halcyon Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Halcyon Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Halcyon Life Sciences Private Limited has 1 active EPFO establishment as of Apr 07, 2024.
GST
Halcyon Life Sciences has 9 GST registrations: 3 active and 6 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AADCK4208J1ZS | Chandigarh | Active | 01 Jul 2017 |
| 03AADCK4208J3ZS | Punjab | Active | 24 Oct 2017 |
| 01AADCK4208J3ZW | Jammu and Kashmir | Active | 15 Dec 2017 |
To see the full GST registrations and return filing status of Halcyon Life Sciences Private Limited, buy the company report.
Recent activity
Halcyon Life Sciences Private Limited has 9 board changes on record since 2009: 2 appointments and 7 cessations. The latest: Anil Kumar Gupta ceased to be Additional Director on 29 Sep 2023.
18 earlier events are in the company report.
Frequently asked questions
Halcyon Life Sciences is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 February 2008 (18+ years old) and is registered under CIN U85190CH2008PTC031103.
Halcyon Life Sciences has 2 current directors:
- Anil Kumar Gupta - Director
- Neeraj Gupta - Director
The latest financial statements of Halcyon Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Halcyon Life Sciences is 04AADCK4208J1ZS, registered in Chandigarh. The company has 9 GST registrations in all, of which 3 are active and 6 are cancelled or inactive. Other active GSTINs include 03AADCK4208J3ZS (Punjab), 01AADCK4208J3ZW (Jammu and Kashmir).
The CIN (Corporate Identification Number) of Halcyon Life Sciences is U85190CH2008PTC031103. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Halcyon Life Sciences has 8 court cases on record: 7 filed by the company and 1 filed against it. 1 is pending. Most are in the high courts.
Halcyon Life Sciences was incorporated on 25 February 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chandigarh.
Halcyon Life Sciences has 9 deals on record (4 funding rounds, 3 secondary share transfers, 1 convertible or debt financing), with disclosed funding of ₹51.54 Cr; the latest was in March 2021.
Anil Kumar Gupta ceased to be Additional Director on 29 Sep 2023. Neeraj Gupta ceased to be Additional Director on 29 Sep 2023. Mohit Arora ceased to be Additional Director on 31 Mar 2023. Halcyon Life Sciences has 9 board changes on record in total.
The registered office of Halcyon Life Sciences is at Plot No 337, Workyard Industrial And Business Park Phase 2, Chandigarh, India – 160002.